Información*
| Nombre | LUIS JESUS CORDOVA BAHENA |
|---|---|
| Área | BIOLOGÍA Y QUÍMICA |
| Campo | CIENCIAS DE LA VIDA |
| Disciplina | FARMACOLOGÍA HUMANA |
| Especialidad | CANCER |
| CVU | 423171 |
| Institución | |
|---|---|
| Dependencia | NO APLICA |
| Entidad | NO APLICA |
| Nivel | 1 |
| Vigencia | Inicio: 01/01/2022 |
| Fin: 31/12/2026 |
* Información del primer trimestre de 2026.
Fuente: SECIHTI.
Últimas publicaciones Scopus
- 2022
- Repositioning of etravirine as a potential CK1ε inhibitor by virtual screening Pharmaceuticals · Vol. 15 Article
- 2020
- Design of Fluorescent Coumarin-Hydroxamic Acid Derivatives as Inhibitors of HDACs: Synthesis, Anti-Proliferative Evaluation and Docking Studies Molecules · Vol. 25 Article
- Anti-PD-1 And Anti-PD-L1 Antibodies as Immunotherapy Against Cancer: A Structural Perspective Revista De Investigacion Clinica Organo Del Hospital De Enfermedades De La Nutricion · Vol. 73 Review
- 2017
- In silico, synthesis and biological investigations of Pyrrolo[3,4-C]pyrrole hydroxamic acid derivatives as potential anticancer agents Journal of the Mexican Chemical Society · Vol. 61 Article
- 2015
- Spirochromone-chalcone conjugates as antitubercular agents: Synthesis, bio evaluation and molecular modeling studies Rsc Advances · Vol. 5 Article
